Contributions to good lay summary practice
The EU Clinical
Trial Regulation requires a lay summary of trial results to be disseminated in
accessible language within 12 months after the end of the study and even
earlier, within 6 months, for paediatric trials. In response to this, the European
Federation of Pharmaceutical Industries and Associations (EFPIA) and
the European Forum for Good Clinical Practice (EFGCP) put in motion the Roadmap
Initiative to Good Lay Summary Practices. The SCTO and EUPATI CH, the Swiss national platform of the
European Patients’ Academy on Therapeutic Innovation, both contributed to this initiative.
In
addition, the SCTO, its Regulatory Affairs Platform, and SwissPedNet contributed to the EU Commission’s public consultation
on recommendations for good lay summary practice. Together with its partner organisation the Swiss Group for Clinical Cancer Research (SAKK), the SCTO submitted comments to
the Good Lay Summary Practice document.
Moreover,
the SCTO and the SAKK developed a concept for two joint events in 2021: the
SCTO Forum and the SAKK Symposium, both of which address good lay summary practice
with the goals to raise awareness of the topic within Switzerland and provide information
on how to best prepare for this new requirement.